Halt Growth of Liver Tumors From Uveal Melanoma With Closure of Liver Artery Following Injection of GM-CSF

PHASE2CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

December 31, 2011

Study Completion Date

June 30, 2012

Conditions
Uveal MelanomaLiver Metastases
Interventions
DRUG

GM-CSF

2,000 mcg injected into the liver every 4 weeks alternating between right or left lobe when tumors present throughout liver.

PROCEDURE

Embolization

A catheter will be introduced to one of the hepatic arteries by way of the femoral artery (groin) to allow injection of GM-CSF in combination with ethiodized oil and gelatin sponge providing a temporary blockage of the blood supply from the hepatic (liver) artery

Trial Locations (1)

19317

Thomas Jefferson University, Philadelphia

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Sidney Kimmel Cancer Center at Thomas Jefferson University

OTHER

NCT00661622 - Halt Growth of Liver Tumors From Uveal Melanoma With Closure of Liver Artery Following Injection of GM-CSF | Biotech Hunter | Biotech Hunter